RBD₂₀₆-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern

Signal Transduct Target Ther. 2021 Nov 10;6(1):390. doi: 10.1038/s41392-021-00798-8.

Authors

Chuge Zhou^#¹, Xiaodong Zai^#¹, Ziqing Zhou¹, Ruihua Li¹, Yue Zhang¹, Yaohui Li¹, Ying Yin¹, Jun Zhang¹, Junjie Xu², Wei Chen³

Affiliations

¹ Beijing Institute of Biotechnology, No. 20 Dongdajie Street, Fengtai District, 100071, Beijing, China.
² Beijing Institute of Biotechnology, No. 20 Dongdajie Street, Fengtai District, 100071, Beijing, China. xujunjie@sina.com.
³ Beijing Institute of Biotechnology, No. 20 Dongdajie Street, Fengtai District, 100071, Beijing, China. cw0226@foxmail.com.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Neutralizing
COVID-19*
Humans
Neutralization Tests
SARS-CoV-2*

Substances

Antibodies, Neutralizing